A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate

Psychiatric Genetics

Volumn 17, Issue 3, 2007, Pages 159-163

  Parsons, Michael J ^a   Mata, Ignacio ^a,b   Beperet, Maria ^b   Iribarren Iriso, Fernando ^b   Arroyo, Barbara ^a   Sainz, Ricardo ^a   Arranz, Maria J ^a   Kerwin, Robert ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Fundacion Argibide   (Spain)

Author keywords

D2 receptors; Dopamine; Polymorphisms; Population isolate; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DOPAMINERGIC SYSTEM; DRD2 GENE; EVIDENCE BASED PRACTICE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POPULATION GENETICS; PRIORITY JOURNAL; SCHIZOPHRENIA; SPAIN;

DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RURAL POPULATION; SCHIZOPHRENIA; SEQUENCE DELETION; SPAIN;

EID: 34248151448     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e328017f8a4     Document Type: Article

References (44)

1. Arinami T, Gao M, Hamaguchi H, Toru M (1997). A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6:577-582.
2. Barr CL, Kidd KK (1993). Population frequencies of the A1 allele at the dopamine D2 receptor locus. Biol Psychiatry 34:204-209.
3. Bertranpetit J, Cavalli-Sforza LL (1991). A genetic reconstruction of the history of the population of the Iberian Peninsula. Ann Hum Genet 55:51-67.
4. Besag J, Clifford P (1991). Sequential Monte Carlo P-values. Biometrika 78:301-304.
5. Blum K, Braverman ER, Wu S, Cull JG, Chen TJ, Gill J, et al. (1997). Association of polymorphisms of dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with schizoid/avoidant behaviours (SAB). Mol Psychiatry 2:239-246.
6. Breen G, Brown J, Maude S, Fox H, Collier D, Li T, et al. (1999). - 141C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. Am J Med Genet 88:407-410.
7. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, et al. (1997). Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94:2569-2574.
8. Buckland PR (2001). Genetic association studies of alcoholism: problems with the candidate gene approach. Alcohol Alcohol 36:99-103.
9. Calafell F, Bertranpetit R (1994). Principal component analysis of gene frequencies and the origin of Basques. Am J Phys Anthropol 93:201-215.
10. Cardon LR, Palmer LJ (2003). Population stratification and spurious allelic association. Lancet 361:598-604.
11. Dubertret C, Gorwood P, Gouya L, Deybach JC, Ades J (2001). Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophr Res 49:203-212.
12. Dubertret C, Gouya L, Nanoun N, Deybach JC, Adès J, Hamon M, Gorwood P (2004). The region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res 67:75-85.
13. Escamilla MA (2001). Population isolates: their special value for locating genes for bipolar disorder. Bipolar Disord 3:299-317.
14. Gejman PV, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D et al. (1994). No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA 271:204-208.
15. Glatt SJ, Faraone SV, Tsuang MT (2004). DRD2 - 141C insertion/deletion polymorphism is not associated with schizophrenia: results of a meta-analysis. Am J Med Genet 128:21-23.
16. Golimbet VE, Aksenova MG, Nosikov VV, Orlova VA, Kaleda VG (2003). Analysis of the linkage of the TaqIA and TaqIA loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings. Neurosci Behav Physiol 33:223-225.
17. Hess EJ, Bracha HS, Kleinmann JE, Creese I. (1987). Dopamine receptor subtype imbalance in schizophrenia. Life Sci 40:1487-1497.
18. Hori H, Ohmori O, Shinkai T, Kojima H, Nakamura J (2001). Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia. Am J Med Genet 105:176-178.
19. Jonsson EG, Brene S, Geijer T, Terenius L, Tylec A, Persson ML, Sedvall G (1996). A search for association between schizophrenia and dopamine-related alleles. Eur Arch Psychiatry Clin Neurosci 246:297-304.
20. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P, Sedvall GC (1999a). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density in healthy volunteers. Mol Psychiatry 4:290-296.
21. Jonsson EG, Nothen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M (1999b). Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophr Res 40:31-36.
22. Kampman O, Anttila S, Illi A, Lehtimaki T, Mattila KM, Roivas M, Leinonen E (2003). Dopamine receptor D2 - 141C insertion/deletion polymorphism in a Finnish population with schizophrenia. Psychiatry Res 121:89-92.
23. Laruelle M, Abi-Dargham A, Van Dyck CH, Gil R, D'Souza CD, Erdos J, et al. (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235-9240.
24. Laruelle M, D'Souza CD, Baldwin RM, Abi-Dargham A, Kanes SJ, Fingado CL, et al. (1997). Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 17:162-174.
25. Laruelle M, Gelernter J, Innis RB (1998). D2 receptors binding potential is not affected by TaqI polymorphism at the D2 receptor gene. Mol Psychiatry 3:261-265.
26. Lee T, Seeman P (1980). Elevation of brain antipsychotic/dopamine receptors in schizophrenia. Am J Psychiatry 137:191-197.
27. Li T, Arranz M, Aitchison KJ, Bryant C, Liu X, Kerwin RW, et al. (1998). Case-control, haplotype relative risk and transmission disequilbrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophr Res 32:87-92.
28. McGuffin P, Farmer A, Harvey I (1991). A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48:764-770.
29. Neville MJ, Johnstone EC, Walton RT (2004). Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23:540-545.
30. Ohara K, Nagai M, Tani K, Nakamura Y, Ino A, Ohara K (1998). Functional polymorphism of -141C ins/del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res 81:117-123.
31. Ottman R (2005). Analysis of genetically complex epilepsies. Epilepsia 46:7-14.
32. Pohjalainen T, Rinnem JO, Nagren K, Lehikoinen P, Anttila K, Syvälahti EKG, Hietala J (1998). The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3:256-260.
33. Sanders AR, Rincon-Limas DE, Chakraborty R, Grandchamp B, Hamilton JD, Fann WE, Patel PI (1993). Association between genetic variation at the porphobilinogen deaminase gene and schizophrenia. Schizophr Res 8:211-221.
34. Schindler KM, Pato MT, Dourado A, Macedo A, Azevedo MH, Kennedy JL, Pato CN (2002). Association and linkage disequilibrium between a functional polymorphism of the dopamine-2 receptor gene and schizophrenia in a genetically homogeneous Portuguese population. Mol Psychiatry 7:1002-1005.
35. Schulze TG, McMahon FJ (2002). Genetic association mapping at the crossroads: which test and why? Overview and practical guidelines. Am J Med Genet 114:1-11.
36. Seeman P (2002). Atypical antipsychotics: mechanism of action. Can J Psychiatry 47:27-38.
37. Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, et al. (2006). Psychosis pathways converge via D2-high dopamine receptors. Synapse 60:319-346.
38. Stober G, Jatzke S, Heils A, Jungkunz G, Knapp M, Mossner R, et al. (1998). Insertion/deletion variant ( - 141C ins/del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar disorder. J Neural Transm 105:101.
39. Suzuki A, Kondo T, Mihara K, Furukori H, Nagashima U, Ono S et al. (2000). Association between TaqI A dopamine D2 receptor polymorphism and psychopathology of schizphrenia in Japanese patients. Progn Neuropsychopharmacol Biol Psychiatry 24:1105-1113.
40. Tallerico T, Ulpian C, Liu IS (1999). Dopamine D2 receptor promoter polymorphism: no association with schizophrenia. Psychiatry Res 85:215.
41. Thompson J, Thomas N, Singleton A, Piggot M, Lloyd S, Perry EK, et al. (1997). D2 dopamine receptor gene (DRD2) taqI A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7:479-484.
42. Virgos C, Martorelli L, Valero J, Figuera L, Civeira F, Joven J, et al. (2001). Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr Res 49:65-71.
43. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, et al. (2001). Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50:825-844.
44. Worrel JA, Marken PA, Beckham SE, Ruehter VL (2002). Atypical antipsychotic agents: a critical review. Am J Health Syst Pharm 57:238-255.